S1416 trial results show PARP inhibitor benefit in “BRCA-like” breast cancer
Results from the SWOG S1416 clinical trial show that adding veliparib to chemotherapy can significantly extend progression-free survival (PFS) times ...
Results from the SWOG S1416 clinical trial show that adding veliparib to chemotherapy can significantly extend progression-free survival (PFS) times ...
With modern therapies for heart failure (HF) with reduced ejection fraction (HFrEF), some patients can improve their cardiac function during ...
A Medical University of South Carolina (MUSC) research team has developed novel compounds that show early promise at fighting the ...
Inhibition of the COQ8 protein could be beneficial in the treatment of diseases such as cancer. COQ8 is needed for ...
“In summary, our study shows that MK256, a potent and selective CDK8 inhibitor, is an effective negative STAT pathway regulator ...
Barcelona, Spain: Preliminary data from a phase I clinical trial of a new drug called NVL-520 for patients with non-small ...
Results from a single-arm phase 2 study of 32 patients with various cancer types harboring the rare AKT1 E17K mutation ...
NB: this presentation will be the subject of an embargoed news briefing by co-author Dr Kevin Kalinsky on Monday 24 ...
Researchers at the University of Illinois Chicago have found a small molecule capable of manipulating an immune process that plays ...
PHILADELPHIA — (SEPTEMBER 19, 2022) — Immune checkpoint inhibitor (ICI) therapy is a type of treatment for melanoma, the deadliest ...
This study is carried out by Prof. Qiang Liu (Breast Tumor Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University). In ...
HOUSTON ― The highly selective RET inhibitor selpercatinib was well-tolerated and achieved durable objective responses across multiple tumor types in ...
Kansas City, MO. – Sept. 12, 2022—BioMed Valley Discoveries (BVD) announced that the first patient has been dosed in a ...
HUNTINGTON, W.Va. – Findings from a new study at the Marshall University Joan C. Edwards School of Medicine show that ...
Credit: Vall d’Hebron Institute of Oncology (VHIO). Published in Cancer Research, findings reveal the potent and prolonged antitumor ...
ANN ARBOR, Michigan — Scientists at the University of Michigan Rogel Cancer Center were optimistic when they identified a small ...
NEW YORK, May 24, 2022 --- Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, today announced its nomination of ...
(Memphis, Tenn.—May 9, 2022) Inhibitors of the protein EZH2 are effective against cancers with SMARCB1 mutations such as rhabdoid tumors ...
NEW ORLEANS – Patients with non-small cell lung cancer (NSCLC) treated with the KRAS G12C inhibitor sotorasib (Lumakras) had a ...
UPTON, NY—When the COVID-19 pandemic hit, scientists across the U.S. Department of Energy’s (DOE) national laboratory complex turned to the ...
We bring you the latest science news from best research centers and universities around the world. Check our website.
© 2022 Scienmag- Science Magazine: Latest Science News.
© 2022 Scienmag- Science Magazine: Latest Science News.